Lihe Chemistry

PharmaceuticalsSeries AWuhan, China

Latest round

Series A

Last raised

Mar 2018

Total raised

$13M

Investors

3

About Lihe Chemistry

Established in 2013 and based in Wuhan, China, Lihe Chemistry operates as a healthcare company that specializes in the production and sales of chemically synthesized active ingredients for pharmaceuticals. The company focuses on the production and sale of chemically synthesized active ingredients for pharmaceuticals. Products include pharmaceutical intermediates and APIs. Pharmaceutical intermediates include esomeprazole sodium and esomeprazole magnesium and their intermediates and major impurities, and aprepitant intermediates. The company generates revenue by providing chemically synthesized active ingredients for pharmaceuticals.

Who invested in Lihe Chemistry

3 investors across 2 rounds

See all investors in Lihe Chemistry

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Mar 13, 2018

    Amount

    $7.9M

    Investors

    Locked

  2. Series A

    Mar 30, 2017

    Amount

    $5.1M

    Investors

    Locked

Questions about Lihe Chemistry

Who invested in Lihe Chemistry?

Lihe Chemistry has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Lihe Chemistry raised?

Lihe Chemistry has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did Lihe Chemistry last raise money?

Lihe Chemistry's most recent round on record is a Series A, in Mar 2018.

What does Lihe Chemistry do?

Established in 2013 and based in Wuhan, China, Lihe Chemistry operates as a healthcare company that specializes in the production and sales of chemically synthesized active ingredients for pharmaceuticals.

Where is Lihe Chemistry headquartered?

Lihe Chemistry is headquartered in Wuhan, China.

Which VCs invest in companies like Lihe Chemistry?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Lihe Chemistry's stage. Their profiles are linked below.

Raising like Lihe Chemistry? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.